Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,931,827
-$548,779 QoQ
Shares Held
31,121
-3.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#640
of 2,266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Financial, LLC holds $139,079,585 across 13 Drug Manufacturers - General names. GILD ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,495 | $37,776,050 | |
| 2 | JNJ |
Johnson & Johnson
|
119,066 | $30,239,192 | |
| 3 | ABBV |
AbbVie Inc.
|
93,109 | $23,429,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
153,789 | $19,761,886 | |
| 5 | AMGN |
Amgen Inc
|
19,430 | $7,035,991 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
91,557 | $5,275,514 | |
| 7 | PFE |
Pfizer Inc
|
192,213 | $4,628,489 | |
| 8 | AZN |
Astrazeneca PLC
|
23,684 | $4,490,960 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,931,827 | 31,121 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,480,606 | 32,149 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,727,859 | 30,372 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,038,403 | 27,373 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,750,241 | 24,806 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,341,060 | 20,893 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,795,118 | 19,434 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $331,168 | 3,950 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $265,040 | 3,863 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||